CTLA-4-directed Blocking Antibody
- Name
- CTLA-4-directed Blocking Antibody
- Accession Number
- DBCAT003464
- Description
Not Available
- Drugs
Drug Drug Description Ipilimumab A human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. Tremelimumab An anti-CTLA-4 antibody used to treat unresectable hepatocellular carcinoma in combination with durvalumab. - Drugs & Drug Targets
Drug Target Type Ipilimumab Cytotoxic T-lymphocyte protein 4 target Tremelimumab Cytotoxic T-lymphocyte protein 4 target